Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1061 clinical trials
Thyroid Cancer and Photoacoustic Imaging

In addition, we would like to confirm the relationship between the results of photoacoustic imaging and histopathologic findings when thyroid nodules were diagnosed as thyroid cancer.

thyroid nodule
photoacoustic imaging
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
The TARGET-EFT Trial

Randomized clinical trial to determine whether a multicomponent intervention will lead to improvements in mobility, self-care, mood, pain, and physical activity among frail and pre-frail older adults (as measured with the Essential Frailty Toolset; EFT) hospitalized for an acute cardiovascular illness.

anemia
malnutrition
  • 0 views
  • 19 Feb, 2024
  • 1 location
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

This trial studies the best time point of using F18-FDG that gives the best image on PET-MRI in patients with spinal cord lesions of unknown cause. Diagnostic procedures, such as F18-FDG PET-MRI, may help find and diagnose spinal cord lesions.

spinal cord
positron emission tomography
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia

A better understanding of the therapeutic and neuromodulatory mechanisms of tDCS as an adjunct to language therapy in nfvPPA may have a significant impact on the development of effective therapies for PPA, and may offer insight into ways of impeding neurodegeneration that may improve patients' quality of life, as well …

transcranial direct current stimulation
neurodegenerative disorder
apraxia of speech
language testing
aphasia
  • 0 views
  • 19 Feb, 2024
  • 1 location
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

measurable disease
monoclonal protein
daratumumab
multiple myeloma
cell transplantation
  • 0 views
  • 24 Nov, 2025
  • 8 locations
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation

All international guidelines recommend 6-monthly ultrasound surveillance for patients at risk for liver cancer (hepatocellular carcinoma or HCC), such as patients with cirrhosis. The aim of surveillance is to detect HCC at an early stage when it is still potentially curable. Currently only 4 out of 10 HCCs are detected …

ascites
cirrhosis
cancer
fibroscan
contrast-enhanced magnetic resonance imaging
  • 0 views
  • 19 Feb, 2024
  • 10 locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

Radiation therapy, such as stereotactic body radiation therapy, uses special equipment to position a patient and deliver radiation to tumors with high precision.

non-small cell lung cancer
ct scan
stage ia2 lung cancer ajcc v8
cancer
neutrophil count
  • 0 views
  • 19 Feb, 2024
  • 22 locations
Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

To investigate the safety and efficacy of an orally administered dose of TW-012R in patients with Alzheimer's disease bearing PSEN1 (presenilin 1) mutations (PSEN1-AD), using a placebo group as a control. In addition, long-term safety will be examined in an open-label extension trial.

mini-mental state examination
alzheimer's disease
dementia
psychiatric disorder
  • 0 views
  • 19 Feb, 2024
  • 7 locations
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

This is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology combined with chemotherapy.

metastatic squamous cell carcinoma
measurable disease
metastatic head and neck squamous cell cancer
squamous cell carcinoma
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Microlearning-Based Health Education for Ambulatory Surgery Patients  

Participants will be patients scheduled for either a mid-urethral sling procedure or a vaginal hysterectomy, and they will complete pre- and post-education surveys as part of the study.

  • 0 views
  • 28 Oct, 2025
  • 1 location